©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Characterization of Calcium Translocation across the Plasma Membrane of Primary Osteoblasts Using a Lipophilic Calcium-sensitive Fluorescent Dye, Calcium Green C(*)

(Received for publication, June 20, 1995; and in revised form, July 17, 1995)

Qin P. Lloyd (1) Michael A. Kuhn (3) Carol V. Gay (1) (2)(§)

From the  (1)Department of Biochemistry and Molecular Biology and the (2)Department of Poultry Science, The Pennsylvania State University, University Park, Pennsylvania 16802 and (3)Molecular Probes, Inc., Eugene, Oregon 97402

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The synthesis of Calcium Green C(18), a lipophilic fluorescent calcium-sensitive dye, and its use as a monitor of Ca efflux from cells is described. This indicator consists of a Calcium Green-1 molecule conjugated to a lipophilic 18-carbon alkyl chain which will intercalate into cell membranes. The K of the indicator for Ca in aqueous solution (pH 7.2, 22 °C, ionic strength 0.1 M) is 0.23 ± 0.04 µM and in the presence of liposomes is 0.062 ± 0.007 µM. Due to its high negativity, the calcium chelating fluorophore faces the cell exterior, when loaded under a defined set of conditions. The dye was found largely on the surface of the cells when loaded at a concentration of 5 µM for 10 min at 37 °C. Five minutes after introduction of EGTA, 83-95% fluorescence disappeared, indicating that most of the fluorophore was on the cell surface. Photobleaching was minimal (3-13%). A confocal laser scanning microscope was used to detect and quantify fluorescence. Internalized dye was apparent in cells loaded for longer times (30-60 min) and in membrane-impaired cells, as shown by uptake of propidium iodide. Under defined confocal laser scanning microscope settings, a transient fluorescence at the periphery of 30% of the cells was observed following 10M parathyroid hormone treatment, indicating the presence of outwardly directed calcium transport across the plasma membrane. Calcium efflux usually lasted 7-10 min, peaking at around 2-3 min. Changes in cell shape were also observed. Calcium efflux was shown to be sensitive to (a) 10 µM quercetin and 10 µM vanadate, partially specific inhibitors of plasma membrane Ca-ATPase, to (b) 0.1 mM trifluoperazine, an agent which renders calmodulin ineffective, and to (c) 10 mM neomycin sulfate, which blocks release of Ca from intracellular stores. Thapsigargin (5 µM), an inhibitor of Ca-ATPase of the endoplasmic reticulum, prolonged fluorescence. These observations indicate that cell surface fluorescence was due to the capture of Ca by Calcium Green C(18) after Ca had been translocated across osteoblast plasma membranes. Involvement of the plasma membrane Ca-ATPase, known to be present in osteoblasts in substantial amounts, is implicated.


INTRODUCTION

Osteoblasts line bone surfaces at sites of bone formation and secrete a protein matrix that has the capacity to calcify. The precise manner by which Ca passes through the layer of osteoblasts to sites of calcification is not known. The demonstration of substantial amounts of a plasma membrane Ca-ATPase in osteoblasts (Akisaka et al., 1988) raised the interesting possibility that the enzyme may be involved in movement of Ca to calcifying sites in bone. More recently, a plasma membrane Ca-ATPase has been cloned and sequenced from human osteoblast cell lines (SAOS-2; HOBIT) and shown to bear high sequence homology to other plasma membrane Ca-ATPases (Kumar et al., 1993). In a preparation of vesicles derived from osteoblast plasma membranes, the magnitude and direction of calcium translocation has been determined (Gay and Lloyd, 1995). Sealed inside-out vesicles took up Ca, implying that the direction of pumping in cells was outward, as has been found for numerous other cell types (Carafoli, 1987; Garrahan and Rega, 1990). The uptake rate by osteoblast plasma membrane vesicles was 9.9 ± 2.3 nmol/mg of protein/min, which falls in the range reported for several other vesicle studies, including red blood cells (Caride et al., 1983), parotid gland (Takuma et al., 1985), neutrophils (Ochs and Reed, 1983), and liver (Kraus-Friedmann et al., 1982). Na/Ca exchange also exists in osteoblasts (Krieger, 1992; Short et al., 1994) and may contribute in a minor way to the Ca efflux observed, as subsequently discussed.

The present study was undertaken to establish characteristics of the fluorophore, Calcium Green C(18), when applied to living cells and to utilize the dye to evaluate calcium efflux in intact osteoblasts. Parathyroid hormone was employed to stimulate an increase in . (^1)This occurs as a consequence of Ca release from intracellular stores as has been shown in other studies of osteoblasts (e.g. Reid et al.(1987), Civitelli et al.(1989)). It was anticipated that the return of [Ca] to prestimulatory levels would involve, in part, efflux by plasma membrane Ca-ATPase activity, since this enzyme system is a major pathway utilized by cells to restore [Ca] to basal levels (Carafoli et al., 1990). The lipophilic calcium-sensitive fluorescent dye, Calcium Green C(18), was selected as a likely candidate for monitoring Ca efflux. Since the fluorophore is hydrophilic and is negatively charged, it is excluded from the lipid bilayer; the lipophilic hydrocarbon chain lodges in the plasma membrane, holding the dye in close proximity to the membrane. We reasoned that Ca, upon emerging from the cell, would be trapped by the fluorophore, which would then fluoresce. A laser scanning confocal imaging system was used to visualize sites of calcium efflux and to measure both the intensity and duration of Ca efflux. Comparisons with another lipophilic calcium-sensitive dye, C(18)-Fura-2, previously reported by Etter et al.(1994) are included under ``Discussion.''


EXPERIMENTAL PROCEDURES

Synthesis of Calcium Green C(18), Tetrapotassium Salt

Calcium Green-1 is a fluorescent indicator of free Ca ions. It consists of a dichlorofluorescein conjugated to an aromatic Ca binding site (BAPTA) through an amide spacer (Haugland, 1992). This indicator can be excited at 488 nm and gives an increase in emission intensity at 530 nm on reversibly binding Ca, with a K(d) for Ca of 0.189 µM. The increase in emission intensity for free Calcium Green-1 in solution is approximately 12-fold. Dichlorofluorescein was chosen as the fluorophore for the synthesis of Calcium Green because it is less pH-sensitive than fluorescein itself and still retains a high quantum yield (0.75 at saturating Ca) when excited at 488 nm.

Based on previous experience with the synthesis of a lipophilic Fura-2 (Etter et al., 1994), we synthesized a lipophilic derivative of Calcium Green-1. The synthesis starts with catalytic reduction of 5,5-dinitro-BAPTA tetramethyl ester to the diamine (Pethig et al., 1989), which is then reacted with 1 eq of stearoyl chloride to give the monosubstituted lipophilic BAPTA tetramethyl ester. This is conjugated to a protected dichlorofluorescein, and the protecting groups on the BAPTA and dichlorofluorescein are hydrolyzed with base. The resulting soapy fluorescent product is purified by reverse-phase chromatography to give pure Calcium Green C(18) tetrapotassium salt. The synthesis of Calcium Green C(18) tetrapotassium salt requires synthesis of four intermediates, shown in Fig. 1.


Figure 1: Synthetic pathway leading to Calcium Green C(18). Roman numerals correspond to the compounds whose synthesis is detailed under ``Experimental Procedures.''



Synthesis of Compound I: 5,5`-bis-Amino-BAPTA Tetramethyl Ester

A solution of 11 g (17.7 mmol) of 5,5`-dinitro-BAPTA tetramethyl ester as described by Pethig et al.(1989) is dissolved in 200 ml of DMF and shaken under hydrogen at 40 p.s.i. for 3 h in the presence of 0.8 g of 10% palladium on charcoal. TLC in ethyl acetate shows the formation of a single new product that is colorless and gives a brown/red product on reaction with ninhydrin. The catalyst is removed by filtration through diatomaceous earth, and the colorless filtrate is concentrated under vacuum to a gray oil, which is stirred with 200 ml of methanol for 1 h to give a gray solid. The solid is filtered and dried to give 7.0 g (88% yield), pure to TLC in ethyl acetate or 5% methanol in chloroform.

Synthesis of Compound II: N-Stearoyl-5,5`-bis-amino-BAPTA Tetramethyl Ester

A solution of stearoyl chloride (1.6 g; 5.4 mmol) in 20 ml of dry DMF is added dropwise over 2 h to a stirring solution of compound I (3.0 g, 5.4 mmol) in 70 ml of dry DMF. TLC analysis in ethyl acetate shows the formation of two UV quenching products. The predominant product runs with an R(f) of 0.4 and reacts with ninhydrin to give a ruddy brown product. The reaction is added to 150 ml of ethyl acetate and washed three times with saturated NaCl and once with pure water. The organic layer is dried over Na(2)SO(4) and evaporated to a tan oil. This is purified over 150 ml of silica gel (40-60 µm) eluted with 20% ethyl acetate, 80% chloroform. Purified fractions are pooled and evaporated to a semicrystalline solid that is recrystallized from methanol to give 1.4 g of pure material (40% yield). NMR in CDCl(3) shows 0.95 ppm of ^3H, t; 1.4 ppm of 27H, s(b); 1.7 ppm of 2H, m; 2.4 ppm of 2H, m; 3.6 ppm of 12H, s; 4.1 ppm of 4H, s; 4.15 ppm of 4H, s; 4.2-4.4 ppm of 4H, d; 6.8 ppm of 2H, d; 7.05 ppm of 2H, d; 7.3 ppm of 2H, s.

Synthesis of Compound III: 5-Carboxy-2,7-dichlorofluorescein Diacetate, Isobutyl Anhydride

The 5-isomer of carboxy-2,7-dichlorofluorescein diacetate is purified from mixed 5 and 6 isomers (Molecular Probes) by repeated crystallization from ethanol. The resulting colorless solid is dissolved in 20 ml of CH(2)Cl(2) at 0 °C with isobutyl chloroformate (4.67 mmol) added. The reaction is stirred for 1 h and is evaporated to a colorless semisolid; ethyl acetate (50 ml) is added, and the insoluble salts are removed by filtration. The filtrate is evaporated and dried for 5 h under high vacuum to give the isobutyl anhydride as a colorless foam (2.2 g; 3.5 mmol, 90% yield). NMR in CDCl(3) shows 1.55 ppm of 6H, s; 2.35 ppm of 6H, s; 3.95 ppm of 1H, s; 4.4 ppm of 2H, q; 6.85 ppm of 2H, s; 7.2 ppm of 2H, s; 7.85 ppm of 1H, s; 8.15 ppm of 1H, d; 8.35 ppm, m.

Synthesis of Compound IV: Calcium Green C(18)Diacetate, Tetramethyl Ester

A solution of Compound III (0.23 g; 0.36 mmol) in 1.5 ml of dry DMF is added dropwise over 0.5 h to a stirring solution of Compound II (0.3 g, 0.36 mmol) in 1.5 ml of dry DMF at 0 °C. After stirring at this temperature for 2 h, TLC in 5% methanol, 95% chloroform shows conversion of the two starting materials to a new product of intermediate R(f). On exposure to ammonia fumes, the product turns dark red and is only weakly fluorescent. The reaction is evaporated at 15 °C to a tan oil, which is purified on silica gel (40-60 µm) eluted with pure ethyl acetate. The pure fractions are combined and evaporated to a tan oil with a mass of 250 mg.

Synthesis of Compound V: Calcium Green C(18), Hexapotassium Salt

Compound IV (0.25 g, 0.19 mmol) is dissolved in 1 ml of dioxane and diluted with 2 ml of methanol. Potassium hydroxide (0.11 g, 1.9 mmol) is dissolved in 0.5 ml of pure water and added to the stirring ester over 10 min. The solution immediately turns red as the acetates are cleaved from the dichlorofluorescein. The reaction is stirred at room temperature for 20 h until TLC in 1:1 CHCl(3):CH(3)OH shows a single fluorescent product with an R(f) of 0.5. Cleavage products are also visible as minor impurities formed in the hydrolysis. The reaction is evaporated, diluted with 5 ml of pure water, and purified twice on 300 ml wet bed volume of lipophilic Sephadex LH-20 eluted with pure water adjusted to pH 8 with the addition of dilute KOH. Pure fractions are combined, frozen, and lyophilized to give 210 mg of red powder. NMR in D(2)O shows 0.7 ppm of 3H, t; 1.0-1.5 ppm of 28H, s(b); 1.6 ppm of 2H, m(b); 2.4 ppm of 2H, s(b); 3.9 ppm of 4H, s; 4.0 ppm of 4H, s; 4.5 ppm of 4H, s; 6.75 ppm of 3H, s; 6.85 ppm of 1H, d; 6.9 ppm of 1H, d; 7.05 ppm of 1H, d; 7.15 ppm of 1H, s; 7.3-7.4 ppm of 2H, m; 7.4 ppm of 2H, s; 7.45 ppm of 1H, d; 8.15 ppm of 1H, d; 8.45 ppm of 1H, s.

Spectral Properties of Calcium Green C(18)

Dissociation constants for Ca were determined in EGTA/CaEGTA-buffered Ca solutions with free Ca concentrations varying between 0 and 1.35 µM in 100 mM KCl and 10 mM MOPS (pH 7.2, 22 °C) using the Calcium Calibration Kit I (Molecular Probes) and an MPF-44B fluorescence spectrophotometer (Perkin-Elmer); excitation, 506 nm; emission, 526 nm; slit widths, 5 nm. Calcium buffers were made by the ``pHimetric'' method of Tsien and Pozzan(1989). Calcium Green C(18) was tested for response to free Ca both in aqueous solution and in the presence of DOPC liposomes at a dye concentration of 1 µM. To create liposomes, 100 µl of 40 mM DOPC (in ethanol) was injected slowly (over 1 min) into vortexing buffers, one that contained 10 mM CaEGTA and one that contained 10 mM EGTA, using a Hamilton Syringe and 23-gauge needle. The buffered DOPC solutions were stirred slowly for 15 min. Calcium Green C(18) in anhydrous dimethyl sulfoxide (1 mM) was then added to both DOPC solutions to achieve a dye to DOPC ratio of 1:400. These solutions were stirred for 45 min to ensure an even distribution of the dye and DOPC, then mixed in graded proportions according to Tsien and Pozzan(1989). The response and affinity of the indicator is dependent on the environment, with an increase in emission intensity of 9-fold in aqueous solution and 3.5-fold in the presence of liposomes. A plot of log(F - F(min)/F(max) - F) versus log [Ca] gives the K) of the indicator (pH 7.2, 22 °C, ionic strength 0.1 M) as 0.23 ± 0.04 µM in aqueous solution and 0.062 ± 0.007 µM in the presence of DOPC liposomes.

Defining Conditions for Loading Calcium Green C(18)into Osteoblasts

Primary osteoblasts were isolated as described previously (Gay et al., 1994). Briefly, cells were scraped from periosteal surfaces of 2-3-week-old chick tibias, after mild enzyme treatment, and cultured on 25-mm glass coverslips in Dulbecco's modified Eagle's medium (Sigma) plus 10% heat-inactivated fetal bovine serum for 6 to 8 days.

Introduction of Calcium Green C(18) into the plasma membranes involved first rinsing osteoblasts adherent to coverslips three times in a reduced calcium balanced salt solution (RCBSS) which contained 127 mM NaCl, 3.8 mM KCl, 1.2 mM KH(2)PO(4), 0.8 mM MgCl(2), 5 mM glucose, and 10 mM HEPES buffer at pH 7.3. The cells were then exposed to 1, 2, 5, or 10 µM Calcium Green C(18), initially dissolved in anhydrous dimethyl sulfoxide, then diluted in RCBSS for 1, 2, 5, 10, 30, or 60 min at room temperature. Cells were rinsed again three times with RCBSS to remove excess indicator. The coverslip was inverted and placed in a Dvorak-Stotler Controlled-Environment Culture Chamber (DSC200, Nicholson Precision Instrument, Gaithersburg, MD) that was preloaded with RCBSS. The 5 µM concentration (with a final concentration of dimethyl sulfoxide at 0.5%) and 10-min loading time were found to be optimal. Propidium iodide (2 µg/ml) was present in the RCBSS in some experiments as a test of cell viability.

Determination of [Ca] in the Reduced Calcium Balanced Salt Solution

Fluo-3 (1 mM, Molecular Probes) was dissolved in anhydrous dimethyl sulfoxide and further diluted to 0.1 mM with RCBSS or with distilled, deionized H(2)O. Fluo-3 (10 µl, 0.1 mM) was added to 500 µl of RCBSS in a 0.7-ml microcell cuvette (type 4, NSG Precision Cell, Inc., Farmingdale, NY), and fluorescence was measured (MPF-44B, Perkin-Elmer; excitation, 506 nm; emission, 526 nm; slit widths, 5 nm). The calcium concentration was determined using a standard Ca concentration curve (0 to 39.8 µM Ca) generated from the Calcium Calibration Buffer Kit II (Molecular Probes). This analysis revealed that the concentration of Ca in RCBSS was 0.22 µM.

Determining Specificity of Membrane Localization and Extent of Photobleaching

In order to demonstrate that the dye was localized specifically in the plasma membrane, Calcium Green C(18)-loaded cells were exposed to 1.2 mM CaC1(2) added to RCBSS which was added through a port in the controlled environment chamber. Patterns of fluorescence were observed in optical sections using the 488 nm laser line, zoom 1.0, 10% neutral density filter, aperture opening 2.7 mm, gain 8, and black level 2 settings on the confocal microscope (Bio-Rad MRC 600). For a control, cells were treated with 50 mM EGTA for 5 min in order to chelate added calcium.

In order to assess the extent of photobleaching, cells were loaded with 5 µM Calcium Green C(18) for 10 min, then placed in buffer that contained 1.2 mM CaCl(2), and exposed to the laser beam every 5 s for 5 min (Table 1).



Characterization of CaEfflux in Osteoblasts Using Calcium Green CAs an Ion Trap

In order to characterize Ca efflux by osteoblasts, cells loaded with Calcium Green C(18) were placed in the Dvorak-Stotler Chamber in RCBSS, and a bolus (20 µl) of PTH (final concentration 10M) was injected through a port into the chamber as a means of increasing [Ca](i). Optical sections, 1.0 micron in thickness, in the x-y plane through cell centers were recorded every 5 s for the first 200 s, then every 60 s thereafter, depending on the duration of the fluorescence due to Ca efflux. Under the chosen settings for the confocal system, the background fluorescence caused by the trace amount of Ca present in RCBSS was negligible. Controls included: thapsigargin (5 µM), an inhibitor of endoplasmic reticulum Ca-ATPase; trifluoperazine (0.1 mM), an inactivator of calmodulin; quercetin (10 µM) and sodium vanadate (10 mM), inhibitors of plasma membrane Ca-ATPase; and neomycin sulfate (10 mM), an inhibitor of phospholipase C and therefore of generation of IP(3), the intracellular signal that causes Ca release from intracellular stores. Cells were pre-incubated with the inhibitors in RCBSS for 10 min at room temperature. RCBSS in the culture chamber also contained the same concentration of each inhibitor. Fluorescence images were recorded, and image analysis was carried out using COMOS commands in the Bio-Rad software package. The image space was divided into pixels (0.17 µm^2 when using the 40times objective lens) and assigned a gray level (on a scale of 1-256) as a measure of fluorescence intensity.

Quercetin, sodium orthovanadate, neomycin sulfate, trifluoperazine, thapsigargin, and HEPES buffer were obtained from Sigma. PTH (bovine, 1-84) was obtained from the National Hormone and Pituitary Agency (Bethesda, MD).


RESULTS

Synthesis and Fluorescence Excitation Spectra of Calcium Green C(18)

The structures of the compounds synthesized, then utilized in the synthesis of Calcium Green C(18), described under ``Experimental Procedures,'' are diagramed in Fig. 1. Fig. 2shows the excitation spectra of 1 µM Calcium Green C(18) in the presence of increasing concentrations of Ca in aqueous solution. As [Ca] increased, the emission intensity (at 530 nm) increased with little shift in wavelength.


Figure 2: Response of Calcium Green C(18) to Ca in aqueous solution. This figure shows the emission response of Calcium Green C(18) (1 µM) in the presence of increasing [Ca]. The buffer solutions have free Ca concentrations from ``zero'' (10 mM EGTA) to 1.35 µM (9 mM CaEGTA, 1 mM K(2)EGTA). The ionic strength of the calibration buffers is 0.1 M (100 mM KCl), and they are buffered to pH 7.20 with 10 mM MOPS. The excitation is at 488 nm with the emission scanned from 490 nm to 575 nm.



Localization and Characterization of the Lipophilic Calcium Green C(18)in Cells

Cells loaded with Calcium Green C(18) that were exposed to 1.2 mM CaCl(2) appeared as rings in optical sections produced by confocal microscopy (Fig. 3A). A low level of cytoplasmic staining was also evident in many cells. This was, however, a minor contribution to total cell fluorescence. Occasionally, cell cytoplasm was intensely fluorescent; this phenomenon coincided with cell death, as these cells were found to stain with propidium iodide. Following the addition of EGTA to the observation chamber, fluorescence of cell peripheries were markedly reduced (Fig. 3B; Table 2). Controls indicated that photobleaching contributed only to a minor extent to the disappearance of the fluorescent images; as shown in Table 1, loss of fluorescence due to photobleaching after a total of 60 scans over a time frame of 5 min ranged between 3 and 13%. Serial optical sections along the z axis of dye-loaded cells further revealed that Calcium Green C(18) was evenly located along peripheries of cells (Fig. 4).


Figure 3: Fig. 3. A, osteoblasts were loaded with Calcium Green C(18) in RCBSS followed by addition of 1.2 mM CaCl(2) to the solution bathing the cells. B, the same cell treated with 50 mM EGTA for 5 min. The fluorescence at the cell periphery (arrows) has largely disappeared. Scale bar = 25 µm.

Fig. 4. These are three optical sections from a series of sections in the x-yplane, parallel to the coverslip of a cell loaded with Calcium Green Cand exposed to 1.2 mMCaCl. The rings of fluorescence diminished in size as the optical sections progressed through the cell. A, section close to the coverslip; B, section through the cell center; C, section at the tip of the cell distal to the coverslip. The decreasing diameter of the cell is evident. Scale bar = 25 µm.

Fig. 5. A series of fluorescence changes as a function of time in Calcium Green C-loaded osteoblasts following 10MPTH application. The increase in fluorescence usually began 10 s after PTH treatment, peaked around 3 min, and gradually decreased in about 7-10 min. Note changes in cell shape, for example at arrows. Time following PTH application was 5 s (A), 10 s (B), 50 s (C), 150 s (D), 250 s (E), and 540 s (F). Scale bar = 50 µm.





Characterization of Calcium Efflux

The plasma membrane of approximately 30% of the 8-day-old cultured osteoblasts were found to fluoresce following PTH stimulation. A rapid and transient increase in fluorescence was observed on the surface of the responding osteoblasts when PTH was added to the cell chamber (Fig. 5). The initial efflux was usually detectable 10 s after the addition of PTH. Fluorescence intensity peaked around 2-3 min and persisted for about 7-10 min. Cell shape changes, including the appearance of cell processes, were observed in some cases after PTH stimulation (Fig. 5).

Quercetin, sodium vanadate, trifluoperazine, and neomycin sulfate substantially impaired Ca efflux, both in magnitude and duration (Table 3). Thapsigargin caused the fluorescence to to persist for 15-17 min (Table 3), nearly twice the time found for untreated controls.




DISCUSSION

In this paper we have described the synthesis and spectral properties of a lipophilic long-chain Ca-sensitive fluorescent dye, Calcium Green C(18), that localizes preferentially in the plasma membrane of cells. Our goal was to utilize this fluorescent Ca-specific probe to monitor Ca translocation out of osteoblasts. The Ca-trapping head group of Calcium Green C(18) facing the external medium served as a reporter of Ca efflux. Conjugation of Calcium Green-1 with a lipophilic tail, 18 carbons long, as shown in Fig. 1, provided a means of situating the fluorescent probe along a lipid-based membrane while preserving the capacity of the indicator to fluoresce. It is likely that the method of loading the dye achieved placement of most of the dye into the plasma membrane with the fluorophore facing the outward direction since added external EGTA abolished fluorescence. Furthermore, the observation that the plasma membrane Ca-ATPase inhibitors, quercetin, vanadate and trifluoperazine, greatly reduced membrane fluorescence (Table 3) indicates that most of the Calcium Green C(18) was loaded in the preferred orientation. If substantial amounts of Calcium Green C(18) had been inwardly oriented, the dye would have fluoresced when [Ca](i) increased whether Ca efflux was inhibited or not. While some fluorescence was observed in the cytosol, it was minor compared to the cell periphery under short (10 min) loading times. At the longer loading times, internal fluorescence was common. Using three-dimensional imaging techniques Calcium Green C(18) has been found useful for demonstrating Ca efflux from primary osteoblasts stimulated with parathyroid hormone. It was also possible to monitor the duration of the response. This is the first study to demonstrate that Calcium Green C(18) can be used to detect Ca efflux from cells.

The spectral response of Calcium Green C(18) to increasing concentrations of Ca in aqueous solution, where the K(d) was 0.23 µM, shows a linear increase in emission intensity in the submicromolar range (Fig. 2). In this state, the lipid tail of the dye is not embedded in a membrane, so the response is expected to differ slightly from that in cells. In the presence of DOPC liposomes (spectra not shown), a linear increase in fluorescence with increasing concentrations of Ca was also observed, but the affinity of the dye for Ca was higher (K(d) = 0.062 µM). The water solubility of this probe is better than for C(18)-Fura-2, as Calcium Green-1 has an extra negative charge. This should facilitate loading the dye into cell membranes from an aqueous solution. Further, once in place in the membrane, dye-dye interactions would be reduced due to the negativity of the head group.

In cultured osteoblasts, Calcium Green C(18) appears to be localized along the entire plasma membrane, except for regions associated with the coverslip. Ca specificity is indicated since the calcium greens have been shown to preferentially bind calcium (Girard et al., 1992). Further, little fluorescence was observed under the chosen confocal settings when cells were bathed with RCBSS, which intrinsically contained trace amounts of Ca. Fluorescence was induced when Ca was added to the RCBSS (Fig. 3A) and then largely disappeared when the Ca-specific chelating agent EGTA was added externally (Fig. 3B). Because of the special orientation of Calcium Green C(18) and its relatively low K(d), it is critical that trace amounts of calcium present in the RCBSS be small. At a Ca concentration present in the RCBSS of 0.22 µM, 50% of the indicator would be free to bind calcium emerging from the cell. The K(d) measured in aqueous solution, rather than in liposomes, is considered to better represent the K(d) of the dye intercalated into the plasma membrane since the fluorescent head group is entirely extracellular and is bathed in aqueous solution.

Another near-membrane Ca concentration indicator has been described recently that consists of Fura-2 conjugated to a lipophilic C(18) alkyl chain (Etter et al., 1994). C(18)-Fura-2 orients in the plasma membrane so that the fluorophore faces from the side to which it was applied. This indicator was found to detect rapid, localized changes in [Ca](i) which are undetectable by water-soluble bulk cytosolic fluorescent Ca indicators. Calcium Green C(18), on the other hand, has a higher negative charge, which would assist in maintaining the outward orientation of the dye in the plasma membrane due to the negative membrane potential of intact cells. In addition, the negativity of Calcium Green C(18) would result in fewer dye-dye interactions once the dye is positioned in the cell membrane. The calcium greens are useful for kinetic analysis due to increased quantum yields on binding Ca (Haugland, 1993). However, since the calcium greens are not ratiometric dyes, they are not useful for measuring ion concentrations accurately. The lower K(d) of Calcium Green C(18) in liposomes than for C(18)-Fura-2 (0.062 µMversus 0.15 µM) indicates that Calcium Green C(18) can be used to detect lower levels of Ca and therefore is more sensitive. In this study we did not use an EGTA/CaEGTA buffer in the assay medium surrounding the cells because of concerns with cell membrane instability. Use of such a buffering system, needs to be explored, however, for detection of very low levels of Ca. The improved sensitivity of the calcium greens has been discussed by Eberhard and Erne(1991). In addition, the calcium greens show increased specificity, speed of response, and higher spatial and temporal resolution (Haugland, 1992). Advantages of Calcium Green C(18) being excitable at longer wavelengths over that of C(18)-Fura-2 include less cellular photodamage and decreased autofluorescence. In addition, Fura-2 may bind to cellular proteins and could lead to alterations in the response of the indicator to Ca (Blatter and Wier, 1990).

The present study is the first direct demonstration of Ca efflux from osteoblasts. The source of Ca is believed to be from intracellular stores since cytosolic calcium in osteoblast cell lines has been shown to increase following PTH treatment (Reid et al., 1987; van Leeuwen et al., 1988; Bidwell et al., 1991; Yamaguchi et al., 1991). The pathways by which increased [Ca](i) is restored to basal levels are incompletely understood but are believed to involve generation of IP(3) (Ferris and Snyder, 1992). In the present study, we have shown that a portion of increased [Ca](i) is handled by a plasma membrane Ca-ATPase-dependent efflux mechanism and that re-entry into intracellular stores formed by the endoplasmic reticulum also occurs. By blocking the latter process with thapsigargin (Thastrup et al., 1987), more cytosolic calcium was available for translocation to the cell exterior as shown by a prolonged fluorescence at the cell surface. An alternative explanation for the prolonged effect could be that ATP-dependent processes in the plasma membrane were partially inhibited by thapsigargin. This possibility is contraindicated by studies which show the specificity of thapsigargin for Ca-ATPase of the endoplasmic reticulum (Lytton et al., 1991). It has been shown that once PTH binds to receptors on the cell membrane, phospholipase C is activated (Lowik et al., 1985). This in turn generates IP(3) which will then bind to the endoplasmic reticulum membrane derived Ca storage compartment, causing Ca to be released. Our experiments show that a substantially reduced amount of Ca efflux occurred in the presence of neomycin sulfate, an inhibitor of phospholipase C and, therefore, IP(3) generation (Bidwell et al., 1991). This supports the view that the Ca that is secreted in response to PTH is derived mainly from intracellular stores, through the IP(3) pathway.

Two major Ca efflux systems are known to exist in the plasma membrane of cells, the ubiquitous Ca-ATPase (Carafoli et al., 1990), and the less widespread Na/Ca exchanger (Carafoli, 1987). The plasma membrane Ca-ATPase has been shown to be present in osteoblasts in substantial amounts (Akisaka et al., 1988; Kumar et al., 1993; Gay and Lloyd, 1995). Na/Ca exchange has also been demonstrated in osteoblasts, but at an unknown level of participation (Krieger, 1992; Short et al., 1994). Typically, excitable tissues have notably high levels of the exchanger, whereas nonexcitable tissues have less or even no Na/Ca exchange (Philipson and Nicoll, 1993). The extent to which the Ca-ATPase and Na/Ca exchange systems may have contributed to this study can be partially assessed from the data in Table 3. The three inhibitors used, trifluoperazine, vanadate, and quercetin, all markedly affect the Ca-ATPase. Na/K-ATPase, the enzyme which drives Na/Ca exchange by creating a sodium gradient, is also affected by these inhibitors. However, while trifluoperazine has been shown to inhibit Na/K-ATPase activity in red blood cell hemolysates, at the concentration we used (0.1 mM), trifluoperazine is more effective (2-5times) in reducing Ca-ATPase activity (Luthra, 1982). In ameloblasts, cells which also form a calcifiable matrix, trifluoperazine has no effect on Na/K-ATPase activity (Sasaki and Garant, 1987). Quercetin, at the concentration we used (10 µM), has almost no effect on eel Na/K-ATPase (Kuriki and Racker, 1976), but has a K(i) = 4-6 µM for Ca-ATPase of erythocytes (Wüthrich and Schatzmann, 1980). Vanadate is also notably effective for red blood cell Ca-ATPase having a K(i) = 5 µM (Niggli et al., 1981). Under some conditions, however, vanadate has been shown to more effective for Na/K-ATPase than for Ca-ATPase (Bond and Hudgins, 1980). Our finding of similar degrees of inhibition of Ca efflux with all three inhibitors, which have widely differing degrees of effectiveness on Na/K-ATPase, suggests that Na/Ca exchange may have made little to no contribution to the Ca-efflux monitored in this study. Further, PTH may have inhibited Na/K-ATPase activity as has been shown in the renal tubule (Ribeiro and Mandel, 1992). However, manipulation of external Na and treatment with ouabain, a specific Na/K-ATPase inhibitor, are needed for critical assessment of the participation of Na/Ca exchange.

It has been reported that parathyroid hormone alters the shape of osteoblasts, usually from a spreadout to a stellate morphology (Egan et al., 1991; Ali et al., 1990). Our observations of cell shape change induced by PTH corroborate the earlier reports.

In summary, this study has provided evidence that Calcium Green C(18) can be employed to monitor Ca efflux by cells. Plasma membrane Ca-ATPase of primary osteoblasts is implicated as having a major role in actively transporting intracellular calcium to the extracellular space. The enzyme activity is calmodulin-dependent and can be partially blocked by Ca-ATPase inhibitors. Also shown is that calcium is released from intracellular stores which utilize the IP(3) pathway upon receiving signals from PTH-occupied receptors; this process is substantially impaired by interfering with IP(3) production. Apparently, when thapsigargin blocks re-entry of intracellular calcium into the endoplasmic reticulum, more calcium is transported through the plasma membrane to the exterior.


FOOTNOTES

*
This work was supported by National Institutes of Health Grant DE09459. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: 108 Althouse Laboratory, University Park, PA 16802. Tel.: 814-865-6722; Fax: 814-863-7024.

(^1)
The abbreviations used are: [Ca], cytosolic free Ca concentration; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N`,N`-tetraacetic acid; DMF, N,N-dimethylformamide; DOPC, L-alpha-dioleoylphosphatidylcholine; MOPS, 3-(N-morpholino)propanesulfonic acid; PTH, parathyroid hormone (bovine, 1-84); RCBSS, reduced-calcium balanced salt solution; IP(3), inositol 1,4,5-trisphosphate.


ACKNOWLEDGEMENTS

Virginia R. Gilman provided technical expertise and Joseph P. Stains editorial assistance.


REFERENCES

  1. Ali, N. N., Melhuish, P. B., Boyde, A., Bennett, A., and Jones, S. J. (1990) J. Bone Miner. Res. 5,115-121 [Medline] [Order article via Infotrieve]
  2. Akisaka, T., Yamamoto, T., and Gay, C. V. (1988) J. Bone Miner. Res. 3,19-25 [Medline] [Order article via Infotrieve]
  3. Bidwell, J. P., Carter, W. B., Fryer, M. J., and Heath, H., III (1991) Endocrinology 129,2993-3000 [Abstract]
  4. Blatter, L. A., and Wier, W. G. (1990) Biophys. J. 58,1491-1499 [Abstract]
  5. Bond, G. H., and Hudgins, P. M. (1980) Biochim. Biophys. Acta 600,781-790 [Medline] [Order article via Infotrieve]
  6. Carafoli, E. (1987) Annu. Rev. Biochem. 56,395-433 [CrossRef][Medline] [Order article via Infotrieve]
  7. Carafoli, E., James, P., and Strehler, E. E. (1990) Prog. Clin. Biol. Res. 332,181-193 [Medline] [Order article via Infotrieve]
  8. Caride, A., Rega, A., and Garrahan, P. (1983) Biochim. Biophys. Acta 734,363-367 [Medline] [Order article via Infotrieve]
  9. Civitelli, R., Martin, T. J., Fausto, A., Gunsten, S. L., Hruska, K. A., and Avioli, L. V. (1989) Endocrinology 125,1204-1210 [Abstract]
  10. Eberhard, M., and Erne, P. (1991) Biochem. Biophys. Res. Commun. 180,209-215 [Medline] [Order article via Infotrieve]
  11. Egan, J. J., Gronowicz, G., and Rodan, G. A. (1991) J. Cell. Biochem. 45,101-111 [Medline] [Order article via Infotrieve]
  12. Etter, E. F., Kuhn, M. A., and Fay, F. S. (1994) J. Biol. Chem. 269,10141-10149 [Abstract/Free Full Text]
  13. Ferris, C., and Snyder, S. (1992) Annu. Rev. Physiol. 54,469-488 [CrossRef][Medline] [Order article via Infotrieve]
  14. Garrahan, P., and Rega, A. (1990) in Intracellular Calcium Regulation (Bronner, F., ed) pp. 271-303, Alan R. Liss, Inc., New York
  15. Gay, C. V., Lloyd, Q. L., and Gilman, V. R. (1994) In Vitro Cell Dev. Biol. 30A,379-383
  16. Gay, C. V., and Lloyd, Q. P. (1995) Comp. Biochem. Physiol., 111A,257-261 [CrossRef]
  17. Girard S., Lückhoff, A., Lechleiter, J. S., and Clapham, D. (1992) Biophys. J. 61,509-517 [Abstract]
  18. Haugland, R. P. (1992) Handbook of Fluorescent Probes and Research Chemicals , 5th Ed, pp 113-121, Molecular Probes, Inc., Eugene, OR
  19. Haugland, R. P. (1993) in Fluorescent and Luminescent Probes for Biological Activity (Mason, W. T., ed) pp. 34-43, Academic Press, New York
  20. Kraus-Friedmann, N., Biber, J., Murer, H., and Carafoli, E. (1982) Eur. J. Biochem. 129,7-12 [Abstract]
  21. Krieger, N. S. (1992) J. Bone Miner. Res. 7,1105-1111 [Medline] [Order article via Infotrieve]
  22. Kumar, R., Haugen, J., and Penniston, J. (1993) J. Bone Miner. Res. 8,505-513 [Medline] [Order article via Infotrieve]
  23. Kuriki, Y., and Racker, E. (1976) Biochemistry 15,4951-4956 [Medline] [Order article via Infotrieve]
  24. Lowik, C. W. G. M., van Leeuwen, J. P. T. M, van der Meer, J. M., van Zeeland, J. K., Scheven B. A. A., and Herrmann-Erlee, M. P. M. (1985) Cell Calcium 6,311-326 [Medline] [Order article via Infotrieve]
  25. Luthra, M. G. (1982) Biochim. Biophys. Acta 692,271-277 [Medline] [Order article via Infotrieve]
  26. Lytton, J., Westlin, M., and Hanley, M. R. (1991) J. Biol. Chem. 266,17067-17071 [Abstract/Free Full Text]
  27. Niggli, V., Adunyah, E. S., Penniston, J. T., and Carafoli, E. (1981) J. Biol. Chem. 256,395-401 [Abstract/Free Full Text]
  28. Ochs, D. L., and Reed, P. W. (1983) J. Biol. Chem. 258,10116-10122 [Abstract/Free Full Text]
  29. Pethig, R., Kuhn, M., Payne, R., Adler, E., Chen, T.-H., and Jaffe, L. F. (1989) Cell Calcium 10,491-498 [Medline] [Order article via Infotrieve]
  30. Philipson, K., and Nicoll, D. (1993) Int. Rev. Cytol. 137C,199-227
  31. Reid, I. A., Civitelli, R., Halstead, L. R., Avioli, L. V., and Hruska, K. A. (1987) Am. J. Physiol. 253,E45-E51
  32. Ribeiro, C. P., and Mandel, L. J. (1992) Am. J. Physiol. 262,F209-F216
  33. Sasaki, T., and Garant, P. R. (1987) Cell Tissue Res. 248,103-110 [Medline] [Order article via Infotrieve]
  34. Short, C. L., Monk, R. D., Bushinsky, D. A., and Krieger, N. S. (1994) J. Bone Miner. Res. 9,1159-1166 [Medline] [Order article via Infotrieve]
  35. Takuma, T., Kuyatt, B. L., and Baum, B. J. (1985) Biochem. J. 227,239-245 [Medline] [Order article via Infotrieve]
  36. Thastrup, O., Foder, B., and Scharff, O. (1987) Biochem. Biophys. Res. Commun. 142,654-660 [Medline] [Order article via Infotrieve]
  37. Tsien, R., and Pozzan, T. (1989) Methods Enzymol. 172,230-262 [Medline] [Order article via Infotrieve]
  38. van Leeuwen, J. P. T. M., Bos, M. P., Lowik, C. W. G. M., and Herrmann-Erlee, M. P. M. (1988) Bone Miner. 4,177-188 [Medline] [Order article via Infotrieve]
  39. Wüthrich, A., and Schatzmann, H. J. (1980) Cell Calcium 1,21-33
  40. Yamaguchi, D. T., Green J., Kleeman C. R., and Muallem S. (1991) Cell Calcium 12,609-622 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.